Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Hughes

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|August 19, 2015
Directing cell therapy to anatomic target sites in vivo with magnetic resonance targetingMunitta Muthana, Aneurin J Kennerley, Russell Hughes, et al.
Blood|May 21, 2009
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaHsin-Yu Fang, Russell Hughes, Craig Murdoch, et al.
Cancer Research|August 14, 2015
Perivascular M2 Macrophages Stimulate Tumor Relapse after ChemotherapyRussell Hughes, Bin-Zhi Qian, Charlotte Rowan, et al.
Signal Transduction and Targeted Therapy|April 29, 2025
Multipronged SMAD pathway targeting by lipophilic poly(β-amino ester) miR-590-3p nanomiRs inhibits mesenchymal glioblastoma growth and prolongs survivalJack Korleski, Sophie Sall, Kathryn M Luly, et al.
Molecular Cancer Therapeutics|December 10, 2020
Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary TumorsAmy Kwan, Natalie Winder, Emer Atkinson, et al.
Oncogene|May 3, 2019
Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesisNadine Rohwer, Sandra Jumpertz, Merve Erdem, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|August 19, 2015
Directing cell therapy to anatomic target sites in vivo with magnetic resonance targetingMunitta Muthana, Aneurin J Kennerley, Russell Hughes, et al.
Blood|May 21, 2009
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaHsin-Yu Fang, Russell Hughes, Craig Murdoch, et al.
Cancer Research|August 14, 2015
Perivascular M2 Macrophages Stimulate Tumor Relapse after ChemotherapyRussell Hughes, Bin-Zhi Qian, Charlotte Rowan, et al.
Signal Transduction and Targeted Therapy|April 29, 2025
Multipronged SMAD pathway targeting by lipophilic poly(β-amino ester) miR-590-3p nanomiRs inhibits mesenchymal glioblastoma growth and prolongs survivalJack Korleski, Sophie Sall, Kathryn M Luly, et al.
Molecular Cancer Therapeutics|December 10, 2020
Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary TumorsAmy Kwan, Natalie Winder, Emer Atkinson, et al.
Oncogene|May 3, 2019
Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesisNadine Rohwer, Sandra Jumpertz, Merve Erdem, et al.
Pageof 3